Financials

  • Market Capitalization 46.66 M
  • Employee 14
  • Founded 2017
  • CEO N/A
  • Website www.werewolftx.com
  • Headquarter Delaware, United States
  • FIGI BBG00QXQ9XK4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.49
Relación precio/flujo de caja
-5.21

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4267
ATYR
aTyr Pharma, Inc. - Common Stock
0.48 USD-9.43%-15.79%-2.04%-50.52%47.08 M USD
4273
TVGN
Tevogen Bio Holdings Inc. - Common Stock
7.17 USD+2.72%+5.60%-0.83%+714.77%46.69 M USD
4279
EDSA
Edesa Biotech, Inc. - Common Shares
4.78 USD+0.84%+6.22%-6.09%+103.40%46.08 M USD
4282
VERU
Veru Inc. - Common Stock
2.69 USD-3.93%-1.47%+15.95%+12.55%45.87 M USD

Noticias